Literature DB >> 7512720

Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation.

S E Nicholson1, A C Oates, A G Harpur, A Ziemiecki, A F Wilks, J E Layton.   

Abstract

Granulocyte-colony-stimulating factor (G-CSF) stimulates the proliferation and differentiation of cells of the neutrophil lineage by interaction with a specific receptor. Early signal transduction events following G-CSF receptor activation were studied. We detected tyrosine phosphorylation of both the G-CSF receptor and the protein tyrosine kinase JAK1 following G-CSF binding to the human G-CSF receptor. In vitro, the kinase activity of JAK1 was increased by G-CSF stimulation. Coimmunoprecipitation of JAK1 with the G-CSF receptor suggested a physical association which existed prior to G-CSF stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512720      PMCID: PMC43499          DOI: 10.1073/pnas.91.8.2985

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.

Authors:  L Pérez; A Paasinen; B Schnierle; S Käch; M Senften; K Ballmer-Hofer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 2.  Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer.

Authors:  A F Wilks
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

3.  The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.

Authors:  M Müller; J Briscoe; C Laxton; D Guschin; A Ziemiecki; O Silvennoinen; A G Harpur; G Barbieri; B A Witthuhn; C Schindler
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

4.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

5.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

6.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.

Authors:  L S Argetsinger; G S Campbell; X Yang; B A Witthuhn; O Silvennoinen; J N Ihle; C Carter-Su
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

7.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

8.  Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.

Authors:  O Silvennoinen; B A Witthuhn; F W Quelle; J L Cleveland; T Yi; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein.

Authors:  K Shuai; C Schindler; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

10.  Signal transduction mediated by growth hormone receptor and its chimeric molecules with the granulocyte colony-stimulating factor receptor.

Authors:  E Ishizaka-Ikeda; R Fukunaga; W I Wood; D V Goeddel; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  38 in total

1.  Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.

Authors:  Roberto Bellucci; Hong-Nam Nguyen; Allison Martin; Stefan Heinrichs; Anna C Schinzel; William C Hahn; Jerome Ritz
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

2.  Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.

Authors:  Kristy Boyle; Jian-Guo Zhang; Sandra E Nicholson; Evelyn Trounson; Jeffery J Babon; Edward J McManus; Nicos A Nicola; Lorraine Robb
Journal:  Cell Signal       Date:  2008-11-12       Impact factor: 4.315

Review 3.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

4.  Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway.

Authors:  O Rausch; C J Marshall
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.

Authors:  Julia E Maxson; Samuel B Luty; Jason D MacManiman; Melissa L Abel; Brian J Druker; Jeffrey W Tyner
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

6.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 7.  A (selective) history of Australian involvement in cytokine biology.

Authors:  Nicos A Nicola
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

8.  CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Authors:  Julia E Maxson; Rhonda E Ries; Yi-Cheng Wang; Robert B Gerbing; E Anders Kolb; Sarah L Thompson; Jaime M Guidry Auvil; Marco A Marra; Yussanne Ma; Zusheng Zong; Andrew J Mungall; Richard Moore; William Long; Patee Gesuwan; Tanja M Davidsen; Leandro C Hermida; Seamus B Hughes; Jason E Farrar; Jerald P Radich; Malcolm A Smith; Daniela S Gerhard; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

Review 9.  Systems approach to phagocyte production and activation: neutrophils and monocytes.

Authors:  Hrishikesh M Mehta; Taly Glaubach; Seth Joel Corey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.

Authors:  Kristina Maas-Bauer; Chrissoula Kiote-Schmidt; Hartmut Bertz; Petya Apostolova; Ralph Wäsch; Gabriele Ihorst; Jürgen Finke; Robert Zeiser
Journal:  Bone Marrow Transplant       Date:  2020-11-17       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.